Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Harrington, R.A.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(20)
+
-
Availability
Open access
(9)
+
-
Metadata Only
(11)
+
-
Creation Date
2019
(8)
+
-
2020
(3)
+
-
2022
(3)
+
-
2023
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(17)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(17)
+
-
Scholarly Publications
(3)
+
-
Topic
alirocumab
(8)
+
-
acute coronary syndrome
(7)
+
-
cholesterol
(4)
+
-
Alirocumab
(3)
+
-
acute coronary syndromes
(3)
+
-
Acute coronary syndrome
(2)
+
-
LDL
(2)
+
-
PCSK9
(2)
+
-
major adverse cardiovascular events
(2)
+
-
Show more
Author
Diaz, R.
(20)
+
-
Harrington, R.A.
(20)
+
-
Jukema, J.W.
(20)
+
-
Bhatt, D.L.
(19)
+
-
Goodman, S.G.
(19)
+
-
Schwartz, G.G.
(19)
+
-
Szarek, M.
(19)
+
-
White, H.D.
(19)
+
-
Steg, P.G.
(18)
+
-
Bittner, V.A.
(17)
+
-
Pordy, R.
(16)
+
-
Zeiher, A.M.
(15)
+
-
Fras, Z.
(12)
+
-
Moriarty, P.M.
(12)
+
-
Ray, K.K.
(12)
+
-
Roe, M.T.
(12)
+
-
Valgimigli, M.
(12)
+
-
Aylward, P.E.
(11)
+
-
Chiang, C.E.
(11)
+
-
Danchin, N.
(11)
+
-
Hagstrom, E.
(11)
+
-
Halvorsen, S.
(11)
+
-
Hanotin, C.
(11)
+
-
Huber, K.
(11)
+
-
Kim, H.S.
(11)
+
-
Kim, S.H.
(11)
+
-
Leonardi, S.
(11)
+
-
Liberopoulos, E.
(11)
+
-
Lopes, R.D.
(11)
+
-
Mahaffey, K.W.
(11)
+
-
Marx, N.
(11)
+
-
Morais, J.
(11)
+
-
Moryusef, A.
(11)
+
-
Nicolau, J.C.
(11)
+
-
Prieto, J.C.
(11)
+
-
Sinnaeve, P.
(11)
+
-
Zahger, D.
(11)
+
-
Abrantes, J.A.M.
(10)
+
-
Alexander, J.H.
(10)
+
-
Alexander, K.
(10)
+
-
Alings, M.
(10)
+
-
Allende, J.C.M.
(10)
+
-
Alvarisqueta, A.F.
(10)
+
-
Amuchastegui, M.
(10)
+
-
Armaganijan, L.
(10)
+
-
Arstall, M.A.
(10)
+
-
Bagai, A.
(10)
+
-
Bahit, M.C.
(10)
+
-
Barakovic, F.
(10)
+
-
Barbato, E.
(10)
+
-
Beauloye, C.
(10)
+
-
Berger, R.
(10)
+
-
Berli, M.A.
(10)
+
-
Blumberg, E.D.S.
(10)
+
-
Bodanese, L.C.
(10)
+
-
Bono, J.O.E.
(10)
+
-
Bordonava, A.P.
(10)
+
-
Brasca, D.F.G.
(10)
+
-
Brennan, J.M.
(10)
+
-
Budaj, A.
(10)
+
-
Caccavo, A.
(10)
+
-
Caime, G.D.
(10)
+
-
Carnero, G.S.
(10)
+
-
Carroll, P.A.
(10)
+
-
Cartasegna, L.R.
(10)
+
-
Caruso, O.C.
(10)
+
-
Castadot, M.
(10)
+
-
Cerqueira, M.J.A.G.
(10)
+
-
Cestari, H.G.
(10)
+
-
Chaitman, B.
(10)
+
-
Chua, T.
(10)
+
-
Chumburidze, V.
(10)
+
-
Claeys, M.
(10)
+
-
Clifton, S.
(10)
+
-
Codutti, O.R.
(10)
+
-
Collins, N.
(10)
+
-
Colombo, H.R.
(10)
+
-
Colquhoun, D.
(10)
+
-
Convens, C.
(10)
+
-
Cools, F.
(10)
+
-
Coverdale, S.G.M.
(10)
+
-
Dalby, A.J.
(10)
+
-
DeVore, A.D.
(10)
+
-
Deloatch, S.
(10)
+
-
Dickey, S.
(10)
+
-
Diepen, S.F.P. van
(10)
+
-
Dilic, M.
(10)
+
-
Dombrowski, K.
(10)
+
-
Dorobantu, M.
(10)
+
-
Dran, R.D.
(10)
+
-
Drexel, H.
(10)
+
-
Ducrocq, G.
(10)
+
-
Duda, N.
(10)
+
-
Dujardin, K.
(10)
+
-
Durak-Nalbantic, A.
(10)
+
-
Duran, R.O.G.
(10)
+
-
Duronto, E.A.
(10)
+
-
Eapen, Z.
(10)
+
-
Edelberg, J.M.
(10)
+
-
Eliaschewitz, F.G.
(10)
+
-
Endsley, P.
(10)
+
-
Eppinger, A.
(10)
+
-
Erglis, A.
(10)
+
-
Faes, D.
(10)
+
-
Fazlibegovic, E.
(10)
+
-
Flores, R.E.O.
(10)
+
-
Flores, R.M.C.
(10)
+
-
Garrahy, P.J.
(10)
+
-
Garrido, M.
(10)
+
-
Giordano, J.A.
(10)
+
-
Giorgeto, F.E.
(10)
+
-
Giuliano, M.E.
(10)
+
-
Gotcheva, N.N.
(10)
+
-
Guneri, S.
(10)
+
-
Guzman, P.N.
(10)
+
-
Hermans, K.
(10)
+
-
Hess, C.N.
(10)
+
-
Hii, C.L.S.
(10)
+
-
Hlatky, M.A.
(10)
+
-
Hoffer, E.
(10)
+
-
Show more
Language
en
(20)
+
-
Search results
(1 - 20 of 20)
show grid
show list
save search
Relating lipoprotein(a) concentrations to cardiovascular event risk after acute coronary syndrome
Lipoprotein(a) and the effect of alirocumab on revascularization after acute coronary syndrome
Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction
Elevated C-Reactive Protein Amplifies Association of Lipoprotein(a) With Cardiovascular Risk and Clinical Benefit of Alirocumab
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes
Apolipoprotein B, residual cardiovascular risk after acute coronary syndrome, and effects of alirocumab
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering
Cost-effectiveness of alirocumab in patients with acute coronary syndromes the ODYSSEY OUTCOMES trial
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes